Cell Therapeutics Inc $3.24

down -0.09


23/4/2014 12:27 PM  |  NASDAQ : CTIC  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get CTIC Trend Analysis - it has outperformed the S&P 500 by 167%

Partner Headlines

  1. Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ...

    GuruFocus
  2. After-Hours Movers: BV, SWHC, AVAV, CTIC Moving Higher, HCI, BOBE, CHEF, ...

    Benzinga
  3. Earnings Scheduled For March 4, 2014

    Benzinga
  4. Mornings Movers for Feb. 27, 2014: PEIX, JCP, SYMX, CIE, SHLD, BBY Higher, ...

    Benzinga
  5. This Week's Sector Gainers And Losers

    Benzinga
  6. Morning Market Losers

    Benzinga
  7. Cell Therapeutics to Reacquire Rights to Two Anti-Cancer Compounds from ...

    Benzinga
  8. Cell Therapeutics Announces Removal of Partial Clinical Hold on Tosedostat

    Benzinga
  9. Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing ...

    Benzinga
  10. Cell Therapeutics Presents Interim Results from Phase 2 Tosedostat Trial ...

    Benzinga
  11. Cell Therapeutics Announces Results from Preclinical Study of Pixantrone ...

    Benzinga
  12. US Stock Futures Signal Lower Start On Wall Street

    Benzinga
  13. Cell Therapeutics Reaches Agreement with FDA on SPA for Planned Pivotal ...

    Benzinga
  14. A Peek Into The Market Before The Trading Starts

    Benzinga
  15. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  16. Cell Therapeutics Says Study Achieved Endpoint Compared to Other Trials

    Benzinga
  17. Cell Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus
  18. Will Cell Therapeutics Stay Above New-Found Support?

    SchaeffersResearch
  19. Bears Set the Bar Low for Cell Therapeutics

    SchaeffersResearch
  20. Cell Therapeutics Prices Offering at $1.40/Common Share

    Benzinga
  21. Stocks End Mixed as Spanish Concerns Linger with General Motors (GM) and ...

    MarketIntelligenceCenter
  22. Morning Market Movers

    Benzinga
  23. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 1 ...

    GuruFocus
  24. Cell Therapeutics' Highly Selective Oral JAK 2 Inhibitor, Pacritinib, Demonstrates ...

    Benzinga
  25. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 4 ...

    GuruFocus
  26. Highs & Lows: Cell Therapeutics, Toll Brothers, Travelers, and Valero Energy

    SchaeffersResearch
  27. Morning Market Movers

    Benzinga
  28. Cell Therapeutics Says Holders Approve SBio Transaction

    Benzinga
  29. Hertz Global Holdings, Zalicus Among Stocks Gapping Up Monday

    FoxBusiness
  30. Ubiquiti Networks, Office Depot Among Stocks falling to Annual Lows Monday

    FoxBusiness
  31. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 5 ...

    GuruFocus
  32. TreeHouse Foods, Alexco Resource Among Stocks hitting 52-Week Lows Thursday

    FoxBusiness
  33. Cell Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus
  34. Cell Therapeutics Inc. (CTIC) President and CEO James A Bianco sells 5 ...

    GuruFocus
  35. Deckers Outdoor, Diamond Foods Among Stocks hitting 52-Week Lows Thursday

    FoxBusiness
  36. Donaldson Company, Rovi Corporation Among Stocks falling to Annual Lows ...

    FoxBusiness
  37. Cell Therapeutics' Pixuvri Approved in European Union as Monotherapy to ...

    Benzinga
  38. European Medicines Agency's Committee For Medicinal Products For Human ...

    Benzinga
  39. These 4 Biotech Stocks Are a Buy Now

    GuruFocus
  40. Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 10,000 Shares

    GuruFocus
  41. Rodman & Renshaw Places Cell Therapeutics Under Review

    Benzinga
  42. Morning Market Losers

    Benzinga
  43. Cell Therapeutics Plummeting on NDA Withdrawl

    Benzinga
  44. From Earlier: Cell Therapeutics Withdraws New Drug Application for Pixuvri ...

    Benzinga
  45. Solar Stocks to watch in the week ahead

    Benzinga
  46. From Earlier: Cell Therapeutic Announces FDA's Oncologic Drugs Advisory ...

    Benzinga
  47. Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 10,000 Shares

    GuruFocus
  48. Call Players Focus Some Attention on Cell Therapeutics

    SchaeffersResearch
  49. Stocks To Watch For December 12

    Benzinga
  50. BoardCentral StockTalk - weekly update: AAPL, BRKA, AMD, WNBD, HEB, CTIC, ...

    BoardCentral
Trading Center